(Q39477114)

12 September 2017

title

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design (English)

1 reference

12 September 2017

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design (English)

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

3 June 2024

0 references

1 reference

M. G. Byas-Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596622

3 June 2024

M. B. Max

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596622

3 June 2024

J. Muir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596622

3 June 2024

A. Kingman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596622

3 June 2024

language of work or name

English

0 references

publication date

1 March 1995

1 reference

full work available at URL

12 September 2017

https://journals.lww.com/10.1016/0304-3959(94)00121-T

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

3 June 2024

1 reference

12 September 2017

volume

60

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

267-274

1 reference

The natural history of acute painful neuropathy in diabetes mellitus

12 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Pain due to peripheral nerve damage: an hypothesis

3 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Painful diabetic neuropathy. A morphometric study

3 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

3 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Single-dose, randomized, double-blind, double-dummy cross-over comparison of extradural and i.v. clonidine in chronic pain

3 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain

3 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

3 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Ratio scales of sensory and affective verbal pain descriptors.

3 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam

3 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Narcotic Analgesia: Fentanyl Reduces the Intensity But Not the Unpleasantness of Painful Tooth Pulp Sensations

3 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Determining optimal therapy--randomized trials in individual patients

3 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

A validation model for verbal description scaling of human clinical pain

3 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Nitrous oxide analgesia: a psychophysical evaluation using verbal descriptor scaling.

3 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials

3 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Desipramine relieves postherpetic neuralgia

3 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

The multi-crossover model for classifying patients as responders to a given treatment.

3 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Randomized clinical trials in single patients during a 2-year period

3 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Optimal crossover designs in the presence of carryover effects.

3 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

3 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

3 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

3 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

3 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

3 June 2024

n of 1 trials

26

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design

3 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

3 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

The differential effects of morphine and the alpha 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain

3 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain.

3 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata.

3 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.

3 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Plasma norepinephrine in sensory diabetic polyneuropathy

3 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Amitriptyline versus placebo in postherpetic neuralgia

3 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

3 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing

3 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

An overview of methods for the analysis of longitudinal data

3 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

Transdermal clonidine versus placebo in painful diabetic neuropathy

3 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00121-T

3 June 2024

Identifiers

1 reference

12 September 2017

1 reference